Repotrectinib available in India
For ROS1-positive NSCLC and eligible NTRK gene fusion-positive solid tumours, Repotrectinib offers a targeted oral treatment option. Check availability and access in India.
CoolPot.com is a place where you can share your Story/ Product/ Review/ Profile URL and get noticed by the world.
Your ads here